Related to this topic: Patient+ | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Xanthelasma
The appearance is of yellow flat plaques over the upper or lower eyelids. In other areas of the body the individual lesion would be called a xanthoma.
Usually not a problem, since colour and site are characteristic. Sometimes syringomas and milia may be misdiagnosed as xanthelasma. Syringomas are small papules on lower eyelids and are skin coloured. Large milial cysts are white and spherical. Xanthomas in other areas may appear more orange-yellow.
Xanthelasma may be associated with familial hyperlipidaemia.1 Patients with these lesions therefore frequently also have arcus senilis and xanthomas in other areas of the body. The presence of xanthelasma and corneal arcus indicates a higher risk of developing ischaemic heart disease, but not peripheral vascular disease.2 Secondary hyperlipidaemia can also be an association, usually caused by underlying uncontrolled diabetes.3 Some patients exhibiting xanthelasma have normal lipid levels.
The lesions can be left alone unless the patient wishes them removed for cosmetic reasons. Various options are available including surgical excision, chemical treatment with trichloracetic acid, carbon dioxide and argon laser treatment, and cryocautery.3
Patients should have their fasting lipid levels checked, and those with hyperlipidaemia should have a formal cardiovascular risk assessment using appropriate charts. If the ten-year risk of cardiovascular disease is assessed at greater than 10%, lifestyle intervention should be considered as per primary prevention of cardiovascular risk protocols . If the risk is 20% or greater, intervention might include the use of aspirin and lipid lowering drugs.4
The condition itself if harmless. Up to 40% of lesions recur after treatment.3 Any associated comorbidity will of course affect prognosis.
Surgical excision and cryocautery may be available in primary care, but it is likely that the other treatment options will require secondary care referral.
Document references
- Heiberg A, Berg K; The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds. Clin Genet. 1976 Feb;9(2):203-33. [abstract]
- Segal P, Insull W Jr, Chambless LE, et al; The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. Circulation. 1986 Jan;73(1 Pt 2):I108-18. [abstract]
- Schmucker T, Hamptom R; Xanthelasma eMedicine.com 2006
- No authors listed, JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005 Dec;91 Suppl 5:v1-52.
Internet and further reading
- Online Journal of Ophthalmology - Xanthelasma Image; Note the arcus too.
DocID: 2992
Document Version: 22
DocRef: bgp24955
Last Updated: 3 Apr 2007
Review Date: 2 Apr 2009
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Xanthelasma' (4 there)Medical reference articles in PatientPlus related to this topic (^ top of page)
ExophthalmosOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
View current health newsMedical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)


Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

